Stocks
Dogwood Therapeutics, Inc.DWTX
NASDAQHealthcareBiotechnology$1.21
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing non-opioid treatments for chronic pain and other neurological conditions. Its lead candidate, DWTX-101, targets the sodium channel NaV1.7, a validated pain target. Investors track the stock for its potential in the large chronic pain market and upcoming clinical data readouts.
52W Range: $1.18-$7.04
Congressional Interest in Dogwood Therapeutics, Inc. (DWTX)
No congressional trades have been disclosed for Dogwood Therapeutics, Inc. (DWTX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading DWTX?
No congressional trades found for this stock.